Dr. Chethana Kanaparthi, MD

Dr. Kanaparthi practices at The University of Kansas Health System Olathe Hospital in Olathe, Kansas, part of The University of Kansas Health System.

Dr. Kanaparthi's NPI, 1295982031, was assigned on August 23, 2008. Dr. Kanaparthi holds Ohio license 35.099426.

Dr. Kanaparthi's primary practice is The University of Kansas Health System Olathe Hospital, at 20333 West 151st Street, Olathe, KS 66061 in Johnson County. The practice phone is (913) 355-4200.

Dr. Kanaparthi's primary practice is The University of Kansas Health System Olathe Hospital in Olathe, Kansas, part of The University of Kansas Health System. Dr. Kanaparthi is also affiliated with The University of Kansas Hospital. The medical group on file is Kansas University Physicians. Dmand AI also links Dr. Kanaparthi to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kanaparthi practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Kanaparthi's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Kanaparthi is licensed in Ohio.

CMS data shows 447 Medicare services from Dr. Kanaparthi across 10 procedure codes in 2024, for 317 Medicare patients. Medicare paid $47,069 for them.

CMS counts 317 Medicare patients who saw Dr. Kanaparthi in 2024. The largest group is 65 to 74, with 169 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kanaparthi's median patient age at 69, with 67% women.

In 2024, Dr. Kanaparthi wrote 390 Medicare Part D claims for 131 patients. 90% of them were for generic drugs. CMS names the drug for 340 of them, across 5 drugs with 11 or more claims each, at $23,630 in total drug cost. In 2023, CMS named 217 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Kanaparthi for performance year 2024, reported through an alternative payment model (APM). Dr. Kanaparthi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 125 procedures of colonoscopy by Dr. Kanaparthi, more than 85% of the clinicians it reports for that procedure.

CMS Open Payments shows 38 general payments to Dr. Kanaparthi from 10 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $251.